ArticleClinical kidney journal2024

Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study.

Thomas Jaeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.